0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Article |

Treatment of Agoraphobia and Panic Attacks

William Matuzas, MD; Richard M. Glass, MD
Arch Gen Psychiatry. 1983;40(2):220-222. doi:10.1001/archpsyc.1983.01790020118013.
Text Size: A A A
Published online

A number of double-blind placebo-controlled studies have demonstrated the efficacy of imipramine hydrochloride1-4 and phenelzine sulfate4-7 in the treatment of phobic disorders, particularly agoraphobia associated with panic attacks. Uncontrolled clinical observations suggest that other "antidepressants" may also be effective. In this issue of the Archives, Zitrin and her New York colleagues present the final results of a study of the treatment of patients with phobic disorders (see p 125). Their study was started in 1972 and described in a preliminary report in this journal.2 Marks and his British colleagues also present in this issue results of a similar investigation, but they arrive at quite different conclusions (see p 153). Briefly, the New York group concludes that imipramine is effective in the treatment of phobic patients with panic attacks. Furthermore, dynamically oriented supportive psychotherapy is as effective as behavior therapy, as long as both lead to confrontation with

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
First page PDF preview

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

Correspondence

CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();